These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23040899)

  • 1. Interventions for youth at high risk for bipolar disorder and schizophrenia.
    McNamara RK; Strawn JR; Chang KD; DelBello MP
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):739-51. PubMed ID: 23040899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders.
    Larson MK; Walker EF; Compton MT
    Expert Rev Neurother; 2010 Aug; 10(8):1347-59. PubMed ID: 20662758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia.
    Correll CU; Smith CW; Auther AM; McLaughlin D; Shah M; Foley C; Olsen R; Lencz T; Kane JM; Cornblatt BA
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):475-90. PubMed ID: 18928412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preface: Use of medications for adolescents with psychotic and bipolar disorders.
    Malla A
    J Affect Disord; 2012; 138 Suppl():S1-2. PubMed ID: 22406336
    [No Abstract]   [Full Text] [Related]  

  • 5. What we know and what we don't know about the treatment of schizoaffective disorder.
    Murru A; Pacchiarotti I; Nivoli AM; Grande I; Colom F; Vieta E
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):680-90. PubMed ID: 21565468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
    Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
    J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Prediction Models in Psychiatry: Toward a New Frontier for the Prevention of Mental Illnesses.
    Bernardini F; Attademo L; Cleary SD; Luther C; Shim RS; Quartesan R; Compton MT
    J Clin Psychiatry; 2017 May; 78(5):572-583. PubMed ID: 27337225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing prodromal stage of bipolar disorder and early onset schizophrenia spectrum disorders during adolescence.
    Kafali HY; Bildik T; Bora E; Yuncu Z; Erermis HS
    Psychiatry Res; 2019 May; 275():315-325. PubMed ID: 30953877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacologic treatment of the early phase of first-episode psychosis in youths.
    Walter G; Wiltshire C; Anderson J; Storm V
    Can J Psychiatry; 2001 Nov; 46(9):803-9. PubMed ID: 11761631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of bipolar disorders].
    Haffen E; Sechter D
    Encephale; 2006 Sep; 32 Pt 2():S531-5. PubMed ID: 17099569
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacotherapy in Children and Adolescents at Clinical-High Risk for Psychosis and Bipolar Disorder.
    Lambert M; Niehaus V; Correll C
    Pharmacopsychiatry; 2016 Nov; 49(6):229-244. PubMed ID: 27737475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical and therapeutical aspects of schizo-affective psychosis.
    Hofmann G
    Psychiatr Clin (Basel); 1983; 16(2-4):207-16. PubMed ID: 6137864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
    Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
    Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing an individualized treatment plan for patients with schizoaffective disorder: from pharmacotherapy to psychoeducation.
    Vieta E
    J Clin Psychiatry; 2010; 71 Suppl 2():14-9. PubMed ID: 21190648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatment of bipolar disorder in children and adolescents.
    Goldstein BI; Sassi R; Diler RS
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):911-39. PubMed ID: 23040907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventative strategies for early-onset bipolar disorder: towards a clinical staging model.
    McNamara RK; Nandagopal JJ; Strakowski SM; DelBello MP
    CNS Drugs; 2010 Dec; 24(12):983-96. PubMed ID: 21090835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome.
    Correll CU; Penzner JB; Frederickson AM; Richter JJ; Auther AM; Smith CW; Kane JM; Cornblatt BA
    Schizophr Bull; 2007 May; 33(3):703-14. PubMed ID: 17478437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission in schizophrenia: analysis in a naturalistic setting.
    Eberhard J; Levander S; Lindström E
    Compr Psychiatry; 2009; 50(3):200-8. PubMed ID: 19374962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.